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ABSTRACT
A 029 DNA fragment containing genes 10 and 11, coding for
the connector protein and the lower collar protein, respectively,
has been cloned in the pBR322 derivative plasmid pKC30 under the
control of the PL promoter of phage lambda. Two polypeptides with
the electrophoretic mobility of proteins plO and pll were label-
led with 35S-methionine after heat induction. The proteins were
characterized as plO and pll by radioimmunoassay and they repre-
sented about 10% and 7%, respectively, of the total E. coli pro-
tein after 4 hours of induction. These proteins represent less
than 1% of the B. subtilis protein in 029-infected cells. Protein
plO has been highly purified from the E.coli cells carrying the
recombinant plasmid. Antibodies raised against the purified pro-
tein plO reacted with the connector protein produced in 029-in-
fected B. subtilis.
INTRODUCTION
The head-tail connecting region in bacteriophages contains
a protein, the connector, that plays a key role in the early
steps of prohead assembly. It has been shown recently in the B.
subtilis phage 029 (1,2) and in the E. coli phages T4 (3) and
lambda (4) that the connector is an oligomer of a single protein
with 12-fold symmetry. This is, therefore, the region at which
the symmetry transition between the lower corner of the phage
head (5-fold symmetry) and the tail (6-fold symmetry) occurs.
According to Hendrix (5), the connector is also an active device
moving the DNA into the phage prohead. In addition, in phage 029,
the connector is essential for the normal prohead elongation (6,7).
Neck-tail complexes of phage 029, composed of proteins plO
(upper collar or connector), p1l (lower collar), p12* (neck ap-
pendages) and p9 (tail), have been isolated and the symmetry of
the neck region (proteins plO and pll) determined (1,2). To stu-
dy the structure of the isolated connector protein, plO, and to
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correlate it with that of the protein assembled in the phage
necks, as well as to determine whether the protein has some ca-
talytic activity that may be relevant to the process of DNA pac-
kaging we undertook the purification of the protein.
In this paper we describe the cloning of genes 10 and 11 in
plasmid pKC30 (8) under the control of the PL promoter of phage
lambda. Four hours after heat induction protein plO (the connec-
tor) represents about 10% of the total E. coli protein whereas it
amounts to less than 1% of the B. subtilis protein in 029-infec-
ted cells. The connector protein synthesized in E. coli has been
isolated in a highly purified form and antibodies against the
purified protein react with protein plO synthesized in 029-infec-
ted B. subtilis.
MATERIALS AND METHODS
Bacterial strains, phage and plasmids
The E. coli strain N99 (X+) and plasmid pKC30 were obtained
from M. Rosenberg (8). The E.coli X lysogen K-12Atrp (XN cI857 A
H1) (K-12AHlAtrp) (9) was obtained from M. Zabeau. B. subtilis
llONA try spo A was as described by Moreno et al. (10). The 029
mutant sus8(50011)sus14(1242) was as described by Garcia et al.
(11). The mutation susl4(1242) produces a delayed lysis pheno-
type (12).
Enzymes
Restriction endonucleases were from New England Biolabs and
were used according to the supplier. The DNA ligase and nuclease
Bal 31 were from Bethesda Research Laboratories, E.coli DNA po-
lymerase I from Boehringer, DNase I from Worthington and fungal
proteinase K from Merck.
DNA preparations and transformation
Plasmid and phage 029 DNA were isolated as described by
Clewell and Helinski (13) and Inciarte et al. (14), respectively.
The 029 DNA fragment Pvu I A (see Fig. 1) was isolated by cen-
trifugation in a 5-20% sucrose gradient as described by Salas
et al. (15). About 4 1'g of the fragment were digested with 4
units of nuclease Bal 31 for 3 min at 30OC in a buffer contain-
ing 20 mM Tris-HCl, pH 8.1, 12 mM CaCl2, 1 mM EDTA and 600 mM
NaCl. After phenol extraction and ethanol precipitation the Bal
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31-treated Pvu I A fragment (2 ug) was blunt-end ligated to Hpa
I-linearized plasmid pKC30 (3 rg) by incubation with T4 DNA li-
gase as described by Garcia et al. (16).
Transformation of competent E. coli cells and detection of
colonies harbouring recombinant plasmids by hybridization to 32P
labelled 029 DNA were carried out as described (16). The recom-
binant plasmids containing 029 DNA sequences were further screened
by restriction analysis to determine the size and the orienta-
tion of the insert.
Protein analysis in cells transformed by the plasmids
The cells were grown at 300C in LB medium with ampicillin
(50 ig/ml). At A420 = 0.46 the bacteria were collected by cen-
trifugation and resuspended in the same volume of minimal media
(17). After 1 h at 300C the temperature was shifted to 420C and,
at the indicated times, samples of 0.05 ml were labelled for 10
min with 10 jCi of 35S-methionine (1200 Ci/mmol, The Radiochemi-
cal Centre, Amersham). When indicated, after the 10 min pulse a
1000 fold excess of cold methionine was added and samples remo-
ved after different times. Samples were subjected to SDS-poly-
acrylamide gel electrophoresis as described below.
To determine protein accumulation the bacteria were grown in
LB medium and samples were taken at different times after the
shift at 420C. The bacteria were concentrated 10-fold by centri-
fugation and resuspension in a buffer containing 100 mM Tris-HCl,
pH 8.0, 200 mM KC1, 1 mM EDTA, 2 mM CaCl2, 10 mM MgCl2, and 5%
glycerol and lysed by sonication. Bacterial debris were removed
by centrifugation for 5 min at 8900 g and the samples subjected
to SDS-polyacrylamide gel electrophoresis.
Polyacrylamide gel electrophoresis
SDS-electrophoresis was carried out either in slab gels con-
taining 10% acrylamide (18) or in 10-20% acrylamide gradients
(12). For the radioimmunoassay of protein plO after electropho-
resis, 4 M urea was present both in the stacking and the separa-
tion gels. The gels were either stained as described by Fairbanks
et al. (19) or dried for autoradiography. Densitometric analysis
was performed on the autoradiographs or on Kodalith orthofilm
copies of the stained gels, using an Optronics digital microden-
sitometer with a 100 jim square raster, connected to a Digital
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PDP 11/45 minicomputer.
Preparation of sera
The neck-tail complexes of 029, containing proteins p9,plO,
pl1 and p12* were isolated from phage particles as described by
Carrascosa et al. (1). Protein plO was purified from E. coli
containing the recombinant plasmid pKC30 X16 as described in this
paper.
Rabbits were immunized with two 100 ipg doses of total pro-
tein, the first time in complete Freund's adjuvant. Serum was
collected one week after the last injection.
Characterization of proteins plO and pll by radioimmunoassay
Cellular extracts of E. coli transformed with the recombi-
nant plasmids prepared as described above were subjected to SDS-
polyacrylamide gel electrophoresis and proteins plO and pll were
detected by radioiinmunoassay carried out as described (16) using
anti neck-tail serum and 5I-protein A (a gift from I. Prieto).
B. subtilis liONA was infected with the 029 mutant sus8(50011)
susl4(1242) and labelled with 35S-sulfate (200 pCi/ml; 25-40 Ci/
mg, The Radiochemical Centre, Amersham) as described by Camacho
et al. (20). After 60 min at 370C the cells were lysed with ly-
sozyme, treated with DNase I and RNase A and the cell debris
were removed by low-speed centrifugation. A control of uninfec-
ted bacteria was labelled and processed in the same way. A ra-
dioimmunoassay was carried out following the procedure developed
by J.A. Melero (personal communication). Briefly, protein A is
bound to wells of a polystyrene multiwell plate followed by in-
cubation first with anti-protein plO serum and then with the
35S-labelled extracts of B. subtilis infected with mutant sus8
(50011)susl4(1242). The bound protein is analyzed by SDS-poly-
acrylamide gel electrophoresis.
RESULTS
Isolation and characterization of recombinants
The restriction fragment Pvu I A containing the late region
of $29 DNA, transcribed from left to right (see Fig. 1), was di-
gested under controlled conditions with nuclease Bal 31 and
blunt-end ligated to plasmid pKC30 linearized with Hpa I (8) .E.
coli N99 (X ) was transformed with the ligation mixture, the amr
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Fig 1. Construction of pKC30 recombinant plasmids cn'caining the
9DNA fragment Pvu I A digested with Bal 31. (I) The filled
circles represent binding sites for B. subtilis RNA polymerase
on 029 DNA and the dashed lines with the arrows the extent and
direction of early transcription (top) and late transcription (bottonX
as described by Sogo et al. (21). (II) Genetic map of 029 DNA
taken from Mellado et al. (22). The location of the Pvu I and
Hin'd III cuts has been taken from Yoshikawa and Ito (23) . The Hind
III cuts are shown below the gene numbers with small arrows. (IIII)
Plasmid pKC30 showing the location of the 02 9 DNA insert . The
direction of transcription of the ampicillin gene and of the .029
genes 10 and 11 from the lambda PL promoter are indicated by arrows.
colonies were screened by hybridization to a 32P-labelled 0291Ui
probe and the positive clones were further checked by Hind III
diges tion . Several recombinant plasmids containing fragment Hind
III D were obtained, indicating the insertion of the Bal 31-di-
gested Pvu I A fragment (see Fig. 1). Insertions of a wide range
of sizes were obtained; in addition, Bal 31 digested asymmuetri-
cally from each end of the Pvu I A fragment. Treatment of the
above recombinant plasmids with Hind III produced, besides the
029 DNA Hind III D fragment, two other ones corresponding to the
fusion of the rest of the 0f2 9 DNA inserted and each of the two
pKC30 fragments of 4 .7 and 1 .6 kb which are present between the
Hind III site of the plasmid and the Hpa I insertion site (see
Fig . 1 ). The analysis of these fragments showed that in the re-
combinant plasmid pKC30 X16 the 029 DNA insert ( - 5 .8 kb) was in
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the correct orientation for transcription from the PL promoter
and in plasmid pKC30 X6 the insert (,- 5.9 kb) was in the opposi-
te orientation. Therefore, Bal 31 had digested about 100 and
2500 nucleotides, respectively, from the right and left ends of
the Pvu I A fragment in plasmid pKC30 X16 and about 300 and 2200
nucleotides, respectively, from the right and left ends of the
fragment in plasmid pKC30 X6.
Protein synthesis directed by the recombinant plasmids
The recombinant plasmids were used to transform the lysogen
E. coli strain K-12AHlAtrp with the thermosensitive cI857 muta-
tion in the lambda repressor. By raising the temperature from
300 to 42 0C the repressor is inactivated allowing the expression
of the genes under the control of the lambda PL promoter. The
above cells, carrying the recombinant plasmids pKC30 X16 or pKC30
X6, were grown at 300C as described in Materials and Methods and
at 30 min, 60 min and 120 min after induction at 42 0C, they were
labelled with 35S-methionine and the proteins analyzed by SDS-
polyacrylamide gel electrophoresis. As shown in Fig. 2, in the
cells transformed with the recombinant plasmid pKC30 X16, with
the 029 DNA insert in the correct orientation for transcription
from the PL promoter, one polypeptide with the same electropho-
retic mobility as the 029 protein plO was clearly labelled after
60 or 120 min at 420C. This polypeptide was not present in the
cells transformed with the control plasmid pKC30. In the case of
plasmid pKC30 X6, with the 029 DNA inserted in the opposite
orientation, the same polypeptide was labelled, although in smal-
ler extent, suggesting that a 029 promoter could be used to trans-
cribe this gene in the plasmid (see later). At 300C, the synthe-
sis of this protein was much smaller than at 420C in the cells
transformed by either recombinant plasmid, pKC30 X16 or pKC30 X6.
A polypeptide with the electrophoretic mobility expected
for protein pll was also labelled after heat induction in the
cells transformed with both recombinant plasmids, pKC30 X16 and
pKC30 X6, although some protein of similar size was also label-
led in the cells transformed with the control plasmid pKC30 (see
Fig. 2). The evidence that the protein labelled in the cells
transformed by the recombinant plasmids was, indeed, pll, was ob-
tained by radioimmunoassay (see later).
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Fig. 2. SDS-polyacrylamide gel electrophoresis of extracts of
cells transformed by the recombinant plasmids, labelled with 35S-
methionine. The cells transformed with the recombinant plasmids
pKC30 X16 or pKC30 X6 or with the control plasmid pKC30 were
grown at 300C and at 30, 60 and 120 min after the shift to 42°C,
labelled and subjected to electrophoresis in 10% acrylamide gels
as described in Materials and Methods. As a control, cells kept
at 300C were labelled at the time of induction and 120 min later.
The starting time of each labelling period (in min) and the tem-
perature of incubation are indicated above the slots. 35S-label-
led 029 structural proteins were used as molecular weight mar-
kers (24).
Characterization of proteins plO and pll by radioimmunoassay
To determine whether the extracts of E. coli transformed
with the recombinant plasmids contained indeed proteins plO and
pll, cells were induced at 420C and, after 120 min, extracts
were subjected to SDS-polyacrylamide gel electrophoresis and the
proteins transferred to two cellulose nitrate papers. One of them
was stained and the other one incubated first with anti-029 neck-
tail serum and then with 125I-protein A. Autoradiography showed
the presence of labelled bands at the position of proteins plO
and pll in the extracts from cells transformed by the recombi-
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Fig. 3. Radioimmunoassay of proteins plO and pll present in ex-
tracts from cells transformed with the recombinant plasmid pKC30
X6. Samples of the extracts were subjected to SDS-electrophore-
sis in slab gels containing 10% acrylamide. The proteins were
transferred from the gel to two sheets of nitrocellulose paper
which were incubated with anti-neck-tail serum and 125I-protein
A (a) or stained with amido black (b), respectively, as descri-
bed in Materials and Methods. c, structural proteins of g29.
nant plasmid pKC30 X6 (Fig. 3a) or pKC30 X16 (not shown). In ad-
dition, a band with the electrophoretic mobility of p12* was
also labelled in the cells transformed by the recombinant plas-
mid pKC30 X6, suggesting the presence of gene 12 in the above
recombinant plasmid. This is in agreement with the fact that
Bal 31 digestion had only removed 300 nucleotides from the right
end of fragment Pvu I A present in the recombinant plasmid pKC30X6.
Protein plO was detected by staining but very low amount of pro-
tein pll was present in the extracts of the transformed cells
(Fig. 3b) due to the fact that protein pll sedimented after low
speed centrifugation (see later).
Stability of proteins plO and pll
Proteins plO and pll induced in E. coli harbouring plasmid
pKC30 X16 were synthesized at a high rate at least up to 2 h af-
ter heat induction (see Fig. 2). To test the stability in E.coli
of the induced proteins, cells transformed with plasmid pKC30
X16 were shifted to 420C, induced for 75 min, incubated 10 addi-
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Fig. 4. Stability of proteins plO and pll. A. E. coli cells ca-
rrying the recombinant plasmid pKC30 X16 were shifted to 420C
and, after 75 min, labelled with 35S-methionine for 10 min (a).
The labelled proteins were chased by addition of a 1000 fold ex-
cess of cold methionine and samples removed at 15 min (b), 30
min (c) and 60 min (d) and subjected to SDS-electrophoresis in
10% acrylamide slab gels. 35S-labelled 029 structural proteins
were used as molecular weight markers in (e). B. E. coli cells
carrying plasmid pKC30 X16 were induced at 420C and at 30 min
(a), 60 min (b), 120 min (c) and 240 min (d) samples were remo-
ved and the extracts, prepared as described in Materials and Me-
thods, were subjected to SDS-electrophoresis in 10% acrylamide
slab gels. 029 structural proteins were used in (e) as molecular
weight markers. After electrophoresis the gel was subjected to
autoradiography (A) or stained (B) as described in Materials and
Methods.
tional min in the presence of 35S-methionine and the labelled
polypeptides chased by addition of an excess of cold methionine.
Figure 4A shows that the two proteins, with the electrophoretic
mobility of plO and pll, were stable after a chase of 1 h.
Taking into account the stability of the proteins and their high
rate of synthesis for at least 2 h it was expected to find pro-
gressive accumulation of proteins plO and pll after heat induc-
tion of cells harbouring the recombinant plasmid pKC30 X16. Fi-
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Table 1. Summary of the purification of protein plO.
lbtal protein, Protein plO, Total protein plO,
mg % mg
Extract 1,404 11 154
DEAE-cellulose 984 8 79
Ammonium sulfate 280 25 70
Phosphocellulose 63 95 60
Ten g of E. coli K-12AHlAtrp cells transformed with the recombi-
nant plasmid pKC30 X16 were ground with alumina and extracted
with buffer A (50 mM Tris-HCl, pH 7.7, 0.3 M KC1), containing
pancreatic RNase (10 pg/ml) and DNase I (5 pg/ml). After 30 min
at 40C the lysate was centrifuged for 15 min at 19,700 g and the
pellet was re-extracted with buffer A. The two supernatants were
pooled and passed through a column of DEAE-cellulose (3.6 cm x
24.3 cm) equilibrated with buffer A. After washing with the same
buffer, the fractions containing the protein were pooled and
precipitated with ammonium sulfate to 43% saturation. The preci-
pitate, containing over 90% of protein plO, was dissolved in
buffer B (50 mM Tris-HCl, pH 7.7, 0.1 M NaCl) and passed through
a column of phosphocellulose (2.9 cm x 24.6 cm) equilibrated
with buffer B containing 5% glycerol). The column was washed
stepwise with 4 volumes of buffer B containing 0.2 M, 0.4 M, 0.6
M, 0.8 M and 1.0 M NaCl, respectively. Protein plO eluted at 0.6
M NaCl essentially free of contaminating proteins. SDS-polyacryl-
amide gel electrophoresis was carried out at the different puri-
fication steps to follow the presence of protein plO. Protein
concentration was determined by the method of Bradford (25).
gure 4B shows that there was a progressive accumulation of pro-
tein plO up to at least 4 h, representing at this time about 10%
of the total E. coli protein. The amount of protein pll was very
low due to the fact that most of pll sediments after low-speed
centrifugation (see later).
Purification of protein plO
The amount of protein plO synthesized in 029-infected B.sub-
tilis represents less than 1% of the total bacterial protein
(data not shown). Since in the E. coli cells transformed with
the gene 10-containing recombinant plasmid pKC30 X16 protein plO
represents about 10% of the total protein after 4 h of heat in-
duction, we used these cells as a source of protein plO for pu-
rification. Lysates were centrifuged as described in the legend
to Table 1. It can be seen in Fig. 5, lanes b and c, that most
of protein pll is lost by low-speed centrifugation of the lysate
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4ig.5. SDS-polyacrylamide gel electrophoresis of purified pro-
tein plO. A. Proteins at various purification steps were subjec-
ted to SDS-electrophoresis in slab gels containing a 10-20% acryl-
amide gradient. After electrophoresis the proteins were stained
as described in Materials and Methods.. (a) structural proteins
of 929 12- particles. (b) lysate (48 jg); (c) extract, (36 jg);
(d) DEAE-cellulose (180 jg); (e) ammonium sulfate (140 pjg); (f)
phosphocellulose, flow-through (80 jg); (g) phosphocellulose,0.4
M NaCl (14 pg); (h) phosphocellulose, 0.6 M NaCl (18 pg). B.Den-
sitometric analysis of purified protein plO (phosphocellulose
fraction).
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Fig. 6. Radioimmunoassay of protein plO synthesized in 029-in-
fected B. subtilis with anti-protein plO serum prepared with the
protein purified from E. coli. B. subtilis infected with the 029
mutant sus8(50011)sus14(1242) or uninfected were labelled and
extracts prepared as described in Materials and Methods. The ra-
dioimmunoassay using anti-protein plO serum prepared with the
protein plO purified from E. coli cells carrying plasmid pKC30
X16 (a and b) or non-immune serum (c and d) was performed as des-
cribed by J.A. Melero (personal communication) and the proteins
retained by the antiserum were subjected to SDS-electrophoresis
in 10% acrylamide slab gels, followed by autoradiography. a and
c, 029 mutant-infected extracts; b and d, uninfected extracts.
whereas most of protein plO remains in the supernatant. Extracts
were passed through a DEAE-cellulose column to remove nucleic
acids. Most of protein plO eluted at 0.3 M KC1 and was precipita-
ted with ammonium sulfate to 43% saturation. Protein plO was
further purified by phosphocellulose chromatography, eluting at
0.6 M NaCl essentially free of contaminating proteins (Fig. 5).
Table 1 gives a summary of the purification. About 60 mg of puri-
fied protein plO were obtained from 10 g of E. coli harbouring
the gene 10-containing recombinant plasmid pKC30 X16.
Crossreaction of protein plO synthesized in 029-infected B. sub-
tilis with serum against protein plO purified from E. coli carry-
ing plasmid pKC30 X16
Protein plO synthesized in E. coli containing plasmid pKC30
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X16, purified as described above, was used to raise antibodies.
A 35S-labelled extract of B. subtilis infected with a 029 mutant
unable to assemble heads (to get plO in soluble form) was reac-
ted with the above anti-plO serum. SDS-polyacrylamide gel elec-
trophoresis of the proteins that were bound to this serum shows
that the only protein specifically retained was plO (Fig. 6a).
Non-immune serum did not react with protein plO from #29-infected
B. subtilis (Fig. 6c). No band with the mobility of protein plO
was obtained from uninfected B. subtilis either with anti-protein
plO serum or non-immune serum (Fig. 6b and d).
DISCUSSION
Fragment Pvu I A contains the sequence coding for proteins
p8 (major head protein), p8.5 (fibers), p9 (tail), plO (connec-
tor), p1l (lower collar), p12 (precursor of the neck appendages)
and probably part of the morphogenetic proteins p7 and p13 (22,
23). After digestion of the fragment with Bal 31 the resulting
mixture was cloned in the Hpa I site of plasmid pKC30 under the
control of the lambda PL promoter. Two recombinant plasmids were
selected, pKC30 X16 and pKC30 X6, with the 029 DNA insert in the
correct orientation for transcription from the PL promoter and
in the opposite one, respectively. After heat induction of the
cells carrying the recombinant plasmids, two proteins with the
electrophoretic mobility of plO (connector) and pll (lower col-
lar) were labelled, which were synthesized in smaller extent at
300C or in the cells transformed with the control plasmid pKC30.
The phage protein p12 might be synthesized, as shown by radio-
immunoassay, but no other viral protein was synthesized, in
agreement with the fact that nuclease Bal 31 had cut 0.1 kb from
the right end and 2.5 kb from the left end of the Pvu I A frag-
ment inserted in plasmid pKC30 X16 and 0.3 kb from the right end
and 2.2 kb from the left end of the fragment inserted in pKC30
X6. The induced proteins were characterized as plO and pll by
radioimmunoassay. It is known that E. coli RNA polymerase can
recognize 029 late promoters in vitro (26). The synthesis of
significant levels of the two proteins, plO and pll, in the cells
transformed with the recombinant plasmid pKC30 X6, with the 029
DNA insert in the opposite direction of transcription from the
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pL promoter, suggests that a $29 late promoter or promoter-like
sequence is present in the inserted fragment and could be recog-
nized by E. coli RNA polymerase. Why the proteins with t.e elec-
trophoretic mobility of plO and pll seem to be induced at 42°C
in the cells transformed with the recombinant plasmid pKC30 X6
is not understood at present.
The two proteins, plO and pll, synthesized in E. coli trans-
formed with plasmid pKC30 X16, were stable for at least 1 h as
shown by a pulse and chase experiment. The accumulation of the
two proteins in E. coli was determined by densitometry of the
stained gels after separation by SDS-polyacrylamide electropho-
resis of the proteins present at different times after the shift
at 420C. The maximal amount of proteins plO and pll accumulated
after 4 h of induction was about 10% and 7%, respectively, of
the total E. coli protein. These proteins represent less than 1%
of the B. subtilis protein in $29-infected cells.
We have purified protein plO from E. coli cells transformed
with plasmid pKC30 X16. About 60 mg of highly purified protein
plO was obtained from 10 g of cells. Antibodies raised against
the purified protein recognize protein plO induced in $29-infec-
ted B. subtilis. Moreover, the purified protein plO aggregates
giving rise to the same type of structures found in the neck
complexes isolated from phage $29 particles (unpublished results).
The structural as well as the functional properties of purified
protein plO are presently being studied.
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